Skip to main content
. 2013 Jul 1;30(3):1045–1052. doi: 10.3892/or.2013.2579

Table II.

EGFR mutation status in the studied lung adenocarcinomas.

EGFR Exon No. of patients Percentage of patients Mutation (presence or absence)/no. of tests performed
EGFR wild-type 18, 19, 20 and 21 64 64/71 (90%) 64/71 (90%)
Exon 19 deletion 19 4 4/7 (57.1%) 7/71 (10%)
Exon 20 insertion 20 1 1/7 (14.3%)
c.2582T>A (L861Q) 21 1 1/7 (14.3%)
c.2369C>T (T790M)/c.2573T>G (L858R) 18 and 21 1 1/7 (14.3%)
No. of disqualified analyses - 4 4/75 (5.3%) -